APA (7th ed.) Citation

Ebrahimi, P., Soleimani, H., Mahalleh, M., Farisi, P., Taheri, M., Ramezani, P., . . . Ebrahimpur, M. (2025). Cardiovascular outcomes of SGLT-2 inhibitors’ subtypes in type 2 diabetes; an updated systematic review and meta-analysis of randomized controlled trials. Journal of Diabetes & Metabolic Disorders, 24(1), . https://doi.org/10.1007/s40200-024-01545-w

Chicago Style (17th ed.) Citation

Ebrahimi, Pouya, et al. "Cardiovascular Outcomes of SGLT-2 Inhibitors’ Subtypes in Type 2 Diabetes; an Updated Systematic Review and Meta-analysis of Randomized Controlled Trials." Journal of Diabetes & Metabolic Disorders 24, no. 1 (2025). https://doi.org/10.1007/s40200-024-01545-w.

MLA (9th ed.) Citation

Ebrahimi, Pouya, et al. "Cardiovascular Outcomes of SGLT-2 Inhibitors’ Subtypes in Type 2 Diabetes; an Updated Systematic Review and Meta-analysis of Randomized Controlled Trials." Journal of Diabetes & Metabolic Disorders, vol. 24, no. 1, 2025, https://doi.org/10.1007/s40200-024-01545-w.